Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
NCT00538525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2012-05-30
Summary
Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer
Conditions
Interventions
- DRUG
-
Doxorubicin, Docetaxel, Cisplatin
Doxorubicin, Docetaxel, Cisplatin
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Adnan Ezzat, MD · KFSH&RC, Riyadh, Saudi Arabia
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
NCT00461344 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00003953 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
NCT00096291 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer
NCT04809844 ·Status: UNKNOWN
-
Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery
NCT00251329 ·Status: UNKNOWN ·Phase: PHASE2
-
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005800 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
NCT00482391 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Breast Cancer
NCT00312208 ·Status: COMPLETED ·Phase: PHASE3
-
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
NCT00006120 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
NCT00091442 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
NCT00201708 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study in Patients With Operable Breast Cancer
NCT00518583 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer
NCT01953445 ·Status: WITHDRAWN ·Phase: PHASE2
-
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
NCT00268918 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
NCT00004125 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.
NCT00471159 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer
NCT02059876 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
NCT00080626 ·Status: TERMINATED ·Phase: PHASE2
-
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
NCT05287308 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
NCT00669591 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer
NCT01862081 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Taxotere
NCT00206505 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer
NCT01206881 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
NCT00415285 ·Status: UNKNOWN ·Phase: PHASE2